The thread has morphed ,it really hasn't a lot to do with the original post which was about a T2 study not a T1 one. The mortality risks for people with T1 have decreased somewhat since pre insulin days! Data from Scotland shows that in recent years mortality rates have improved considerably. (in spite of fewer than 13% of Scottish T1s achieving less than 7%HbA1c ).
.
http://www.eurekalert.org/pub_releases/2013-09/d-uss092413.php
I don't think that the original paper mentioned has actually been linked to, if not it's here:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612791/#!po=44.2308
FB quotes the results of the DCCT/EDIC study (seemingly favourably) and concludes
Of course -it is how good control is achieved that makes all the difference
Intensive control is what many of us try to do now compared with the conventional therapy of the time. I think it's a great shame that many are still not shown any methods of doing this. .
Conventional therapy was simply one or two injections a day with no targets other than
avoiding the symptoms of hypo and hyperglycemia.
Intensive therapy in the DCCT included:
- 3 or more injections a day or the use of a pump.
- self monitoring at least 4 times a day with targets of 3.9mmol/l to 6.7mmol/l pre meals and less than 10mmol/l after meals.
- HbA1c target: less than 6.05% (but see results)
- Insulin self- adjusted according to diet and exercise.
- individualised advice on diet (and exercise) : Individual strategies to compile diets and adjust insulin (Healthy Food Choices, exchange systems, carbohydrate counting, and total available glucose.(TAG there are threads on this on the forum )
- diet composition goals : initially 10–25% protein, 30–35% fat, 45–55% carbohydrate, a polyunsaturated:saturated fat ratio of 0.8:1.0, and <600 mg cholesterol . The study protocol was amended in 1988 in response to the National Cholesterol Education Program (≤30% fat, ≤10% saturated fat, and <300 mg cholesterol) with further advice/medication if LDL cholesterol targets weren't achieved.
- Consistency of carb amounts and meal times was stressed as important. (This seems to differ from DAFNE , my own doctor/dietitan still stress this, and personally I find better/.easier control when I do this .However being able to be able to be more flexible also has benefits for lifestyle)
Some results :
1) Average HbA1c in the intensive group was 7.2% (It was 9.1% in the conventional group).
(so they didn't achieve the HbA1c target)
2)Those who had greater residual insulin found it easier to keep to achieve lower levels as did those who developed T1 at older ages(tended to have more own insulin) and those on pumps
3) Complication risk increased as HbA1cs above 7% and increased sharply at over 8%. Going below 7% didn't reduce the risks by much
Levels below 6.5 % increased risk of serious hypos (almost mirror image of complication graph)
(this was using older insulins than most of us use now ie NPH or lente rather than lantus/levimir which have flatter profiles and regular insulin which needs pre-meal dosing rather than rapid insulin which acts quicker and also the newer doesn't last as long in the body as regular )
The well known risk/hypo graph
http://www.medscape.org/viewarticle/560226
4) Analysis of available data suggests that it was the HBA1c or average that mattered rather than the everyday ups and downs of glucose levels.
Consistency in HbA1c was also important (ie not good to have periods of low HbA1cs followed by higher ones)
(see Kilpatrick analyses)
6)Those that reported following the meal plans tended to have lower HbA1cs.
http://care.diabetesjournals.org/content/16/11/1453.full.pdf+html
In the intensive arm, diets higher in fat and saturated fat and lower in carbohydrate are associated with worse glycemic control, independent of exercise and BMI
http://ajcn.nutrition.org/content/89/2/518.full#T2
NB This trial was almost stopped early on because of the early worsening of retinopathy with fast reductions in HbA1c. (It's why people should now be recommended to lower levels gradually)
After the trial (EDIC)
the HbA1cs of those in the IT arm rose , but the better control seen during the trial seemed to have a residual beneficial effect.
Importantly, 30 years after the trial there have been persistently reduced complications in the intensive arm.
86.7% of that risk reduction was explained by between-group differences in HbA1c levels
There has for example been a 39% reduced risk of microalbuminuria and a 61% reduced risk of macroalbuminuria in the intensive arm. (P<0.0001 for both).
http://www.medpagetoday.com/MeetingCoverage/ADA/40047
I think that is a really important finding. (and may be significant for mortality rates). A very recent Danish analysis of mortality in T1 showed that life expectancy was much improved but that kidney disease could be an important factor in those that had reduced longevity. Those that avoided it now tended to have a near normal life span.
http://www.ncbi.nlm.nih.gov/pubmed/23949580